Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.
Stock Information for Pluristem Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.